Chicago study suggests knowledge of PrEP is not crossing over to women
Antiretroviral therapy at time of conception associated with some adverse birth outcomes
The vaginal ring against HIV: regulatory approval for a new prevention choice for women
Cardiovascular risk prediction tools aren't accurate in people with HIV
Many people in African PrEP programmes stop and restart PrEP
Depo Provera may worsen tenofovir-related bone loss in young women
A second study finds introducing PrEP to Africa considerably reduces HIV infections in women
At least 28,000 women in the United States have started PrEP
PrEP prevents an estimated three-quarters of HIV infections in people at risk in large African study
